Circassia Pharmaceuticals Plc Non-Executive Director Retirements (1742D)
25 April 2017 - 4:02PM
UK Regulatory
TIDMCIR
RNS Number : 1742D
Circassia Pharmaceuticals Plc
25 April 2017
Circassia Announces Non-Executive Director Retirements
Oxford, UK - 25 April 2017: Circassia Pharmaceuticals plc
("Circassia" or "the Company"; LSE: CIR) today announces the
retirement of Non-Executive Directors Charles Swingland and Dr Tim
Corn from its Board. Both have informed the Company that after
serving for more than 10 years they will remain on the Board until
the Company's Annual General Meeting on 26 May 2017, at which they
will not seek re-election.
Dr Francesco Granata, Circassia's Chairman, commented: "On
behalf of the Board and the wider Company, I would like to thank
both Charles and Tim for their significant contributions to the
development of Circassia over the last 10 years. They have brought
great experience and wisdom to the role, and their advice and
counsel has been highly valued. Both the Board and Company will
miss their valuable input and we wish them well."
-Ends-
For further information, please contact:
Circassia
Steve Harris, Chief Executive Tel: +44 (0)1865 405 560
Officer
Julien Cotta, Chief Financial
Officer
Rob Budge, Corporate Communications
FTI Consulting Tel: +44 (0) 20 3727 1000
Ben Atwell / Simon Conway
/ Mo Noonan
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOALLFEESAISFID
(END) Dow Jones Newswires
April 25, 2017 02:02 ET (06:02 GMT)
Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2024 to May 2024
Circassia (LSE:CIR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Circassia Group Plc (London Stock Exchange): 0 recent articles
More Circassia Pharmaceuticals News Articles